Under construction – not a live service
Sign in
Taking people in United StatesNo phase

Faster Programming of a Vagus Nerve Stimulator in Adults With Epilepsy

Compares two ways of programming a vagus nerve stimulator in adults with epilepsy.

Plain-language title generated from the registry record
Registry title: VNS Algorithm for Advanced Dosing

Key facts

Where
Augusta, United StatesSee the site

Could this be for you?

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 75 years old?

Source: NCT07725601, who can take part

Where in United States

  • Wellstar MCG HospitalAugusta, United StatesTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Fernando Vale
Trial code
NCT07725601
Record updated
24 July 2026
Original description
The goal of this clinical trial is to compare the standard programming of the VNS device (Control) to a modified programming (Augusta Way) in adults with epilepsy. The main question it aims to answer is:Read full original descriptionShow less

VNS Algorithm for Advanced Dosing: Example Guided Mode Titrations "The Augusta Way"

The goal of this clinical trial is to compare the standard programming of the VNS device (Control) to a modified programming (Augusta Way) in adults with epilepsy. The main question it aims to answer is:

Does the modified programming of the VNS reduce seizures faster than the standard programming?

Participants in both groups will:

1. Attend up to 3 study visits every 3 months for 2 years 2. Answer questionnaires to assess quality of life and cognitive function 3. Maintain a diary of seizure activity

Inclusion: Subjects who are clinically determined to be candidates for VNS implantation for seizure control; Subject/legally authorized representative able to provide informed consent.

Exclusion: Subjects with VNS system treating pathologies other than drug refractory epilepsy or medical co-morbidities that prevent any surgical intervention.

ClinicalTrials.gov NCT07725601